The activation of human lung mast cells may induce the release of lymphangiogenic factors including vascular endothelial growth factor C [29] which can result in pulmonary lymphangiectasia and pleural effusions [30]. The gene discussed is VEGFC; the disease is Pulmonary lymphangiectasia.